Verastem (VSTM) Consolidated Net Income (2011 - 2026)

Verastem (VSTM) recorded quarterly Consolidated Net Income of -$44.0 million in Q1 2026, down 151.53% quarter-over-quarter from $85.4 million in Q4 2025, and down 1.33% on a YoY basis from -$44.6 million in Q1 2025.

Verastem (VSTM) Consolidated Net Income (2011 - 2026) Analysis & Trends

Verastem's Consolidated Net Income history runs 16 years deep, the most recent figure standing at -$44.0 million for Q1 2026.

  • In Q1 2026, Consolidated Net Income fell 1.33% year-over-year to -$44.0 million; the TTM figure through Mar 2026 stood at -$41.5 million (up 68.34% YoY), while the FY2025 annual figure was -$209.5 million, down 60.33% from the prior year.
  • Consolidated Net Income was -$44.0 million for Q1 2026 at Verastem, down from $85.4 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $85.4 million in Q4 2025 to a low of -$44.0 million in Q1 2026.
  • Historically, Consolidated Net Income has averaged -$21.4 million across 5 years, with a median of -$22.0 million in 2022.
  • Biggest YoY gain for Consolidated Net Income was 367.0% in 2025; the steepest drop was 133.52% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$16.8 million in 2022, then tumbled by 80.88% to -$30.4 million in 2023, then retreated by 5.19% to -$32.0 million in 2024, then jumped by 367.0% to $85.4 million in 2025, then plunged by 151.53% to -$44.0 million in 2026.
  • The last three Consolidated Net Income figures came in at -$44.0 million (Q1 2026), $85.4 million (Q4 2025), and -$39.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn -43.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -43.98 Mn
Dec 31, 2025 85.35 Mn
Sep 30, 2025 -39.85 Mn
Jun 30, 2025 -43.04 Mn
Mar 31, 2025 -43.41 Mn
Dec 31, 2024 -31.97 Mn
Sep 30, 2024 -37.35 Mn
Jun 30, 2024 -18.43 Mn
Mar 31, 2024 -27.82 Mn
Dec 31, 2023 -30.39 Mn
Sep 30, 2023 -20.19 Mn
Jun 30, 2023 -20.29 Mn
Mar 31, 2023 -19.14 Mn
Dec 31, 2022 -16.80 Mn
Sep 30, 2022 -18.11 Mn
Jun 30, 2022 -21.96 Mn
Mar 31, 2022 -16.99 Mn
Dec 31, 2021 -16.48 Mn
Sep 30, 2021 -22.79 Mn
Jun 30, 2021 -16.90 Mn